http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0500589-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9089461ee71353d9df911820ff129558 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-463 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate | 1990-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8509b93457a0372a3043f1b93f4d77a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28a3dd4abdd61b47eac9be5d57ab0b42 |
| publicationDate | 1992-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0500589-A1 |
| titleOfInvention | PURIFIED PROTEIN AND BIO-ACTIVE PHARMACEUTICAL PRODUCT. |
| abstract | The rana pipiens eggs are fertilized and the embryos are brought to a predetermined stage of development. Embryos and unfertilized eggs are then subjected to mechanical treatment in the presence of a weakly acidic buffer to produce an extract. The extract is subjected to ion exchange chromatography and dimensional exclusion chromatography. The resulting pharmaceutical product is active against certain cancer cells. The amino acid sequence and the composition of the pharmaceutical product are the subject of the invention. When the pharmaceutical product is combined with other products sold under the trademarks of TAMOXIFEN and STELAZINE, the combination with TAMOXIFEN has unexpected bioactivity in vitro against cells affected by human pancreatic adenocarcinoma ASPC-1 and the combination with STELAZINE has unexpected bioactivity in vitro against cells affected by human lung carcinoma. |
| priorityDate | 1989-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 91.